The 5 analysts offering 12-month price forecasts for Dare Bioscience Inc have a median target of 5.00, with a high estimate of 7.50 and a low estimate of 3.00. The median estimate represents a +376.19% increase from the last price of 1.05.
The current consensus among 5 polled investment analysts is to Buy stock in Dare Bioscience Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.17
Reporting Date Nov 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.